Crown Bioscience, a JSR Life Sciences company, has announced its pivotal role in several scientific innovation projects funded by European grants. These projects aim to advance cancer treatments and the development of the tools to do so, employing cutting-edge techniques such as organoid and ex vivo patient tissue technologies, with the goal of bridging the gap between research and patient care. With collaborative efforts among small and medium-sized businesses, academic institutions, and enterprise companies, these initiatives will enhance R&D partnerships and advance the development and commercialization of lead compounds and novel oncology therapeutics.

For details, please see the announcement.

Innovation Funding and Crown Bioscience: Collaborating to Discover the Next Wave of Oncology Therapies